National Institute on Aging; Amended Notice of Meeting, 48902 [2024-12649]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
48902
Federal Register / Vol. 89, No. 112 / Monday, June 10, 2024 / Notices
Information Collection
1. Type of Information Collection
Request: Revision with change of a
previously approved collection; Title of
Information Collection: Notice of Denial
of Medical Coverage (or Payment)—
NDMCP; Use: Section 1852(g)(1)(B) of
the Social Security Act (the Act)
requires Medicare health plans to
provide enrollees with a written notice
in understandable language of the
reasons for the denial and a description
of the applicable appeals processes.
Regulatory authority for this notice is
set forth in Subpart M of Part 422 at 42
CFR 422.568, 422.572, 417.600(b), and
417.840.
Medicare health plans, including
Medicare Advantage plans, cost plans,
and Health Care Prepayment Plans
(HCPPs), are required to issue form
CMS–10003 to Medicare Advantage
plan enrollees when a request for either
a medical service or payment is denied
in whole or in part. The notice explains
to the enrollee why the plan denied the
service or payment and informs
Medicare enrollees of their appeal
rights. Form Number: CMS–10003
(OMB control number: 0938–0829);
Frequency: Yearly; Affected Public:
Private Sector; Business or other forprofits, Not-for-profit institutions;
Number of Respondents: 970; Total
Annual Responses: 18,232,560; Total
Annual Hours: 3,037,544. (For policy
questions regarding this collection
contact Sabrina Edmonston at (410)
786–3209.)
2. Type of Information Collection
Request: Revision with change of a
previously approved collection; Title of
Information Collection: Notice of Denial
of Medicare Prescription Drug Coverage;
Use: Part D plan sponsors are required
to issue the Notice of Denial of Medicare
Prescription Drug Coverage notice when
a request for a prescription drug or
payment is denied, in whole or in part.
The written notice must include a
statement, in understandable language,
the reasons for the denial and a
description of the appeals process.
The purpose of this notice is to
provide information to enrollees when
prescription drug coverage has been
denied, in whole or in part, by their Part
D plans. The notice must be readable,
understandable, and state the specific
reasons for the denial. The notice must
also remind enrollees about their rights
and protections related to requests for
prescription drug coverage and include
an explanation of both the standard and
expedited redetermination processes
and the rest of the appeal process. Form
Number: CMS–10146 (OMB control
number: 0938–0976); Frequency: Yearly;
VerDate Sep<11>2014
17:13 Jun 07, 2024
Jkt 262001
Affected Public: Private Sector; Business
or other for-profits, Not-for-profit
institutions; Number of Respondents:
772; Total Annual Responses:
2,962,857; Total Annual Hours: 740,714.
(For policy questions regarding this
collection contact Coretta Edmonston at
(410) 786–0512.)
3. Type of Information Collection
Request: Reinstatement of a previously
approved collection; Title of
Information Collection: Prospective
Payments for Hospital Outpatient
Services and Supporting Regulations in
42 CFR 413.65; Use: Section 1833(t) of
the Act, as added by section 4523 of the
Balanced Budget Act of 1997 (the BBA)
requires the Secretary to establish a
prospective payment system (PPS) for
hospital outpatient services. Successful
implementation of an outpatient PPS
requires that CMS distinguish facilities
or organizations that function as
departments of hospitals from those that
are freestanding, so that CMS can
determine which services should be
paid under the OPPS, the clinical
laboratory fee schedule, or other
payment provisions applicable to
services furnished to hospital
outpatients. Information from the
reports required under sections
413.65(b)(3) and (c) is needed to make
these determinations. In addition,
section 1866(b)(2) of the Act authorizes
hospitals and other providers to impose
deductible and coinsurance charges for
facility services but does not allow such
charges by facilities or organizations
which are not provider-based.
Implementation of this provision
requires that CMS have information
from the required reports, so it can
determine which facilities are providerbased. Form Number: CMS–R–240
(OMB control number: 0938–0798);
Frequency: Occasionally; Affected
Public: Private Sector (Business or other
for-profits, Not-for-Profit Institutions);
Number of Respondents: 2032; Total
Annual Responses: 15,138,400; Total
Annual Hours: 683,670. (For policy
questions regarding this collection
contact Emily Lipkin at 410–786–3633.)
William N. Parham, III,
Director, Division of Information Collections
and Regulatory Impacts, Office of Strategic
Operations and Regulatory Affairs.
[FR Doc. 2024–12583 Filed 6–7–24; 8:45 am]
BILLING CODE 4120–01–P
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Institute on
Aging Special Emphasis Panel, June 20,
2024, 10:00 a.m. to June 20, 2024, 05:30
p.m., National Institute on Aging,
Gateway Building, 7201 Wisconsin
Avenue, Bethesda, MD 20892 which
was published in the Federal Register
on May 24, 2024, 89 FR 45908.
The meeting notice is amended to
change the start date of the meeting
from 6/20/2024 to 6/28/2024. The
meeting is closed to the public.
Dated: June 5, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–12649 Filed 6–7–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Proteostasis
and Lung Aging.
Date: July 17, 2024.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kaitlyn Noel Lewis
Hardell, Ph.D., M.P.H., Scientific Review
Officer, Scientific Review Branch, National
Institute of Aging, 7201 Wisconsin Avenue,
Gateway Bldg., Room: 2E405, Bethesda, MD
20814, (301) 555–1234, kaitlyn.hardell@
nih.gov.
E:\FR\FM\10JNN1.SGM
10JNN1
]]>Agencies
[Federal Register Volume 89, Number 112 (Monday, June 10, 2024)]
[Notices]
[Page 48902]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-12649]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Institute on Aging Special Emphasis Panel, June 20, 2024, 10:00 a.m. to
June 20, 2024, 05:30 p.m., National Institute on Aging, Gateway
Building, 7201 Wisconsin Avenue, Bethesda, MD 20892 which was published
in the Federal Register on May 24, 2024, 89 FR 45908.
The meeting notice is amended to change the start date of the
meeting from 6/20/2024 to 6/28/2024. The meeting is closed to the
public.
Dated: June 5, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-12649 Filed 6-7-24; 8:45 am]
BILLING CODE 4140-01-P
